tradingkey.logo

Femasys Inc

FEMY
View Detailed Chart

0.820USD

+0.000+0.02%
Market hours ETQuotes delayed by 15 min
22.21MMarket Cap
LossP/E TTM

Femasys Inc

0.820

+0.000+0.02%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.02%

5 Days

-8.91%

1 Month

-11.97%

6 Months

-27.45%

Year to Date

-25.47%

1 Year

-21.92%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts
BUY
Current Rating
7.250
Target Price
784.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Femasys Inc
FEMY
4
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(1)
Buy(0)
Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.017
Sell
RSI(14)
35.176
Neutral
STOCH(KDJ)(9,3,3)
14.740
Oversold
ATR(14)
0.039
High Vlolatility
CCI(14)
-140.783
Sell
Williams %R
86.000
Oversold
TRIX(12,20)
-0.341
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.836
Sell
MA10
0.863
Sell
MA20
0.897
Sell
MA50
0.908
Sell
MA100
1.081
Sell
MA200
1.147
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
Ticker SymbolFEMY
CompanyFemasys Inc
CEOMs. Kathy Lee-Sepsick
Websitehttps://www.femasys.com/
KeyAI